Methods of treating lupus by administering humanized anti-interleukin 3 receptor alpha chain antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 17, 2013
Grant Date -
Apr 4, 2013
app pub date -
Feb 17, 2011
filing date -
Feb 18, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present disclosure provides a method for treating lupus, Sjörgen's syndrome or scleroderma, the method comprising administering to the mammal an immunoglobulin which binds an interleukin 3 receptor α (IL-3Rα) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (p DCs) and basophils to which it binds.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully